St. Jude Comprehensive Cancer Center

A National Cancer Institute Comprehensive Cancer Center

Elaine Tuomanen, MD and Dr. Jason Rosch, MD

Cholesterol-lowering drug shows promise against serious infections in sickle cell disease

New research suggests a family of widely used cholesterol-lowering drugs might help protect individuals from serious illness following bacterial infection, including the pneumococcal infections that pose a deadly threat to those with sickle cell disease.

Read More Read Full Story

St. Jude's Scientific Report 2009

Scientific Report

Key research activities and publications by the investigators at St. Jude during 2008 are summarized in the Scientific Report 2009.